The life sciences sector is at a crossroads as the FDA updates quality management standards. AI is now expected, and the FDA’s January 2025 draft guidance outlines its evaluation and implementation. Successful adoption depends on three key questions.
Safe and Sane: Understanding the FDA’s Risk-Based Approach to AI
Related Posts
5 Reasons Why Your Business Needs App Rationalization
A Brief Overview of Application Rationalization Why Businesses Should Rationalize Applications? 5 Business Benefits of Application Rationalization Challenges…
What is a “Higbee cut”? And Other Related Thread Terms
Understanding industry terminology is vital for success, especially for newcomers and seasoned professionals in new roles. This article…
Larsen Manufacturing Lead Inspector Honored as 2024 Inspector of the Year from ASQ’s Inspection Division
The ASQ Inspection Division has selected Larsen Manufacturing PPAP Lead Inspector, Jair Velazquez Abundez, as the 2024 Chuck…